Viewing nowMemantine Tablets (Memantine Hydrochloride)
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Choeil Pharmaceutical Co., Ltd.

MFDS item code 201708084 · Approved 2017.11.27 · Insurance code 645405100
Treatment of moderate to severe Alzheimer's disease
This medication is used to improve symptoms in patients with moderate to severe Alzheimer's disease.
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver can periodically check that the patient is taking the medicine. Diagnosis should be made in accordance with currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be reassessed periodically. This medicine is administered orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1–7) Administer 5mg daily for 7 days. Week 2 (Days 8–14) Administer 10mg daily for 7 days. Week 3 (Days 15–21) Administer 15mg daily for 7 days. From Week 4 onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). For patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. For patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.
This drug should not be used in patients with hypersensitivity to the ingredients, severe liver dysfunction, or severe kidney impairment. It should be administered with caution in patients with epilepsy or a history of seizures, and in patients taking NMDA antagonists. Patients with conditions that may increase urinary pH should be monitored closely, and caution is needed in patients with heart disease or uncontrolled hypertension. While taking this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, so symptoms should be closely monitored. Neuropsychiatric symptoms such as confusion, hallucinations, and seizures have also been reported; immediate consultation with medical personnel should occur if such symptoms arise. Drug interactions may occur when taken with other medications, especially NMDA antagonists, antipsychotics, muscle relaxants, and anticoagulants, so consultation with a specialist is necessary. Pregnant women or nursing mothers must consult a doctor before taking this medication, and women of childbearing potential should be administered cautiously. It is advisable not to use this medicine in children and adolescents under 18 years as safety and efficacy have not been established. In case of overdose, central nervous system symptoms and gastrointestinal symptoms may occur, requiring immediate hospital visit for appropriate treatment. This medication may affect the patient's reaction speed and concentration, so special care should be taken when driving or operating machinery. Finally, keep this product out of reach of children and avoid transferring the drugs to another container.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to air and moisture; therefore, it must be stored in a tightly sealed container. Additionally, it is preferable to avoid direct sunlight and store at room temperature between 1°C and 30°C.
White elongated film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 10mg
Tablet · Prescription medication
Choeil Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.